Hideki Tanzawa Selected Research

Mouth Neoplasms (Oral Cancer)

1/2021	Engineered exosomes delivering specific tumor-suppressive RNAi attenuate oral cancer progression.
1/2019	UNC93B1 promotes tumoral growth by controlling the secretion level of granulocyte macrophage colony-stimulating factor in human oral cancer.
1/2019	Growth suppression of human oral cancer cells by candidate agents for cetuximab-side effects.
1/2019	Centromere Protein N Participates in Cellular Proliferation of Human Oral Cancer by Cell-Cycle Enhancement.
12/2018	FBLIM1 enhances oral cancer malignancy via modulation of the epidermal growth factor receptor pathway.
1/2018	Critical role of deoxynucleotidyl transferase terminal interacting protein 1 in oral cancer.
1/2018	Overexpression of Translocation Associated Membrane Protein 2 Leading to Cancer-Associated Matrix Metalloproteinase Activation as a Putative Metastatic Factor for Human Oral Cancer.
1/2018	Multiple coagulation factor deficiency protein 2 as a crucial component in metastasis of human oral cancer.
1/2018	Evaluation of tryptophan-aspartic acid repeat-containing protein 34 as a novel tumor-suppressor molecule in human oral cancer.
1/2018	Diacylglycerol lipase alpha promotes tumorigenesis in oral cancer by cell-cycle progression.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hideki Tanzawa Research Topics

Disease

65	Neoplasms (Cancer) 01/2019 - 02/2002
53	Squamous Cell Carcinoma of Head and Neck 08/2020 - 03/2002
34	Mouth Neoplasms (Oral Cancer) 01/2021 - 03/2002
17	Carcinogenesis 01/2018 - 06/2004
15	Neoplasm Metastasis (Metastasis) 11/2019 - 07/2005
6	Carcinoma (Carcinomatosis) 08/2020 - 10/2005
6	Lymphatic Metastasis 01/2017 - 03/2002
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2013 - 06/2003
3	Hypoxia (Hypoxemia) 01/2016 - 03/2011
3	Adenoid Cystic Carcinoma (Cylindroma) 04/2006 - 09/2005
2	Hepatocellular Carcinoma (Hepatoma) 02/2013 - 04/2012
2	Pleomorphic Adenoma 04/2006 - 09/2005
2	Adenocarcinoma 04/2006 - 09/2005
1	Infections 09/2020
1	Immune System Diseases (Immune Disorders) 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Human Influenza (Influenza) 01/2019
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019
1	Exanthema (Rash) 01/2019
1	Herpes Simplex Encephalitis (Herpes Encephalitis) 01/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Chronic recurrent multifocal osteomyelitis 12/2018
1	Protein Deficiency 01/2018
1	Disease Progression 01/2018
1	Type 2 Diabetes Mellitus (MODY) 09/2017
1	Periodontitis 09/2017
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2017

Drug/Important Bio-Agent (IBA)

39	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2002
21	Biomarkers (Surrogate Marker)IBA 05/2018 - 06/2005
20	Messenger RNA (mRNA)IBA 01/2018 - 02/2002
9	Cisplatin (Platino)FDA LinkGeneric 04/2017 - 04/2005
7	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2019 - 08/2005
6	Complementary DNA (cDNA)IBA 01/2021 - 10/2003
5	Small Interfering RNA (siRNA)IBA 01/2021 - 06/2007
5	DNA (Deoxyribonucleic Acid)IBA 12/2007 - 06/2003
3	ErbB Receptors (EGF Receptor)IBA 01/2019 - 12/2018
3	Cetuximab (Erbitux)FDA Link 01/2019 - 01/2018
3	Immunoglobulins (Immunoglobulin)IBA 01/2016 - 07/2012
3	CateninsIBA 06/2014 - 08/2011
2	PlatinumIBA 01/2018 - 02/2013
2	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 04/2013
2	Fluorouracil (Carac)FDA LinkGeneric 04/2017 - 04/2012
2	plastinIBA 01/2017 - 02/2006
2	VimentinIBA 01/2017 - 03/2013
2	UbiquitinIBA 01/2017 - 02/2006
2	ZincIBA 01/2017 - 11/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2016 - 08/2015
2	KinesinsIBA 09/2015 - 01/2013
2	Mitogen-Activated Protein KinasesIBA 08/2015 - 05/2015
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 05/2015 - 07/2005
2	Metalloproteases (Metalloproteinases)IBA 01/2015 - 05/2012
2	EnzymesIBA 01/2015 - 03/2011
2	antineoplaston A10 (A 10)IBA 01/2012 - 01/2010
2	GTP Phosphohydrolases (GTPases)IBA 11/2010 - 11/2007
2	Superoxide DismutaseIBA 07/2010 - 11/2009
2	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 07/2010 - 07/2005
2	OligonucleotidesIBA 12/2007 - 09/2005
2	Lamin Type A (Lamin A)IBA 02/2006 - 07/2005
2	Protein Isoforms (Isoforms)IBA 02/2006 - 01/2006
2	superoxide dismutase 2IBA 02/2006 - 07/2005
2	StathminIBA 02/2006 - 07/2005
1	Penicillins (Penicillin)FDA Link 09/2020
1	Anti-Infective Agents (Microbicides)IBA 09/2020
1	PotassiumIBA 08/2020
1	Antineoplastic Agents (Antineoplastics)IBA 08/2020
1	Oxonic AcidIBA 08/2020
1	gimeracilIBA 08/2020
1	TegafurIBA 08/2020
1	Cell Adhesion MoleculesIBA 11/2019
1	TetraspaninsIBA 11/2019
1	ResveratrolIBA 01/2019
1	Levodopa (L Dopa)FDA LinkGeneric 01/2019
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019
1	inulin trinicotinate monomethochloride (L-3)IBA 01/2019
1	Tripartite Motif ProteinsIBA 01/2019
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2019
1	Clopidogrel (Plavix)FDA Link 12/2018
1	FilaminsIBA 12/2018
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2018
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2018
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2018
1	Tryptophan (L-Tryptophan)FDA Link 01/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018
1	Aspartic Acid (Aspartate)FDA Link 01/2018
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2018
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2018
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2017
1	Aldo-Keto ReductasesIBA 04/2017
1	Mefenamic Acid (Pontal)FDA Link 04/2017
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2017
1	Transcription Factor 4IBA 01/2017
1	Keratins (Keratin)IBA 01/2017
1	Ubiquitin-Conjugating EnzymesIBA 01/2017
1	Microfilament Proteins (Actin Binding Proteins)IBA 01/2017

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2018 - 04/2005
7	Therapeutics 01/2019 - 06/2007
2	Neoadjuvant Therapy 01/2015 - 04/2012
2	Radiotherapy 04/2013 - 11/2005
1	Glycemic Control 09/2017